TTrialPathMatch Me to Trials
← Back to trials
RecruitingPhysical InactivityOverweight and Obesity

A Pilot Factorial Trial of an Integrated Lifestyle Intervention

Eligible age

18–65 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study plans to learn more about the feasibility and acceptability of integrating the Move physical activity support program within an existing lifestyle intervention program.

Sponsor: University of Colorado, Denver

You may qualify if…

  • For all types of research participants:
  • Men and Women
  • Age 18-65 years
  • Have access to a computer and/or smart phone, and Wi-Fi
  • Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)
  • For the patient participants only:
  • Body Mass Index 25-45 kg/m2
  • Insufficiently active (defined as \<150 min/week of voluntary exercise at moderate intensity over the past 3 months)

You may not qualify if…

  • For patient participants:
  • Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).
  • Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded
  • Self-reported cardiovascular disease:
  • Cardiac, peripheral vascular, or cerebrovascular disease
  • Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication
  • Self-reported end-stage renal disease
  • Self-reported diabetes (history of type 1 or type 2 diabetes)

Where it's recruiting

Colorado

Aurora

Source: ClinicalTrials.gov · NCT06116435 · last updated 2024-05-14